We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Confocal Microscopy of Benign and Malignant Skin Tumors

This study has suspended participant recruitment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01010321
First Posted: November 10, 2009
Last Update Posted: June 29, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose
The investigators speculate that this tool may be used as an alternative and convenient non-invasive diagnostic of skin cancer.

Condition Intervention
Skin Cancer Device: confocal microscopy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Confocal Microscopy of Benign and Malignant Skin Tumors

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Primary Outcome Measures:
  • efficacy of a confocal microscope as a diagnostic tool [ Time Frame: 1 year ]

Estimated Enrollment: 60
Study Start Date: November 2009
Estimated Study Completion Date: November 2010
Estimated Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
all study Population
all
Device: confocal microscopy
non-invasive imaging

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Men and women over the age of 18

- Skin lesion suspected to either BCC,SCC etc

Criteria

Inclusion Criteria:

  • Men and women over the age of 18
  • Skin lesion suspected to either BCC or SCC etc
  • Patient was referred for biopsy diagnostic/therapeutic before hand, and regardless of confocal microscope examination, according to the clinical consideration of physician

Exclusion Criteria:

  • Pregnant women
  • Children
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01010321


Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Aviv Barzilai, Dr. Sheba Medical Center
  More Information

Responsible Party: Dr. Aviv Barzilai, Sheba Medical Cener, Dermatology Unit
ClinicalTrials.gov Identifier: NCT01010321     History of Changes
Other Study ID Numbers: SHEBA-09-7295-AB-CTIL
First Submitted: November 2, 2009
First Posted: November 10, 2009
Last Update Posted: June 29, 2010
Last Verified: June 2010

Keywords provided by Sheba Medical Center:
skin lesion suspect as BCC or SCC or others

Additional relevant MeSH terms:
Skin Neoplasms
Neoplasms by Site
Neoplasms
Skin Diseases